What IDIBAPS does

IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer) is a Barcelona-based biomedical research institute founded in 1996 that translates laboratory science into clinical practice. It organizes its work around 101 research groups and seven core scientific platforms: a Biobank, Medical Statistics, Magnetic Resonance Imaging, Cytometry and Cell Separation, Functional Genomics, Clinical Trials Unit, and Scientific Computing. The institute serves physicians, clinical researchers, and biomedical scientists, and supervises approximately 100 doctoral theses per year alongside roughly 25 scientific seminars annually.

The institute is structured as a multi-institutional public research consortium rather than a commercial entity. It is anchored by Hospital Clínic de Barcelona (clinical environment) and Universitat de Barcelona (academic affiliation), with institutional support from Generalitat de Catalunya and membership in the CERCA network of Catalan research centers. Funding flows from competitive grants awarded by bodies such as Instituto de Salud Carlos III, the European Union framework programmes, and philanthropic organizations including the Asociación Española Contra el Cáncer, supplemented by block institutional funding. Pricing is not applicable because IDIBAPS does not commercialize products or services; outputs are scientific publications (over 1,200 original articles per year), trained researchers, clinical-trial support, and knowledge and technology transfer back to Hospital Clínic and the broader research ecosystem.

The operating footprint is concentrated at a single headquarters location at Centre Esther Koplowitz in Barcelona (C/Rosselló 149-153), where platforms and research groups are co-located with the affiliated tertiary hospital. Activity indicators — 930+ active competitive projects, recurring international collaborations, and a published 2025-2028 Strategic Plan — evidence sustained operations and incremental capability build-out (e.g., recent onboarding of high-depth multiomics instrumentation such as MACSima™). The renewed European HR Excellence in Research seal (July 2026) reinforces the institute's role as a publicly funded, translational research entity rather than a productized or revenue-generating business.

Name

IDIBAPS

Legal name

IDIBAPS

Website

https://idibaps.org

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

501–1,000 employees

Short description

IDIBAPS is a Barcelona-based biomedical research institute that runs 101 research groups across seven scientific platforms (biobank, genomics, MRI, cytometry, biostatistics, clinical trials, and scientific computing) to translate laboratory science into patient care, funded primarily through competitive public grants.

Ownership category

akta.pro rank

Product category

Biomedical Research Services

NAICS

Scientific Research and Development Services (5417), Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

akta.pro secondary industries

Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC)

Keywords

• Biomedical research services
• Translational medicine
• Clinical trials support
• Scientific core platforms
• Clinical simulation training

Headquarters

HQ city

Barcelona

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Revenue model

1. Competitive Research Funding: IDIBAPS operates as a publicly funded research institute receiving grants and competitive project funding from national and international sources including Instituto de Salud Carlos III, European Union frameworks, and other research funding bodies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

IDIBAPS is a public biomedical research institute that conducts translational research to bridge laboratory science and clinical patient care. It operates seven shared scientific platforms (biobank, medical statistics, MRI, cytometry, functional genomics, clinical trials, and scientific computing) that serve 101 research groups and over 2,300 professionals. The institute also delivers doctoral research training and clinical simulation education (SIMClínic), and runs knowledge and technology transfer programs linking Hospital Clínic and University of Barcelona research outputs to clinical practice.

Product overview

IDIBAPS operates as a unified biomedical research institute offering seven core scientific platforms as its primary infrastructure services: Biobank, Medical Statistics, Magnetic Resonance Imaging, Cytometry and Cell Separation, Functional Genomics, Clinical Trials Unit, and Scientific Computing. These platforms function as integrated research support services available to affiliated research groups. Additionally, IDIBAPS provides training through SIMClínic (clinical simulation) and facilitates knowledge and technology transfer. The institute does not offer commercial software products but rather provides shared research infrastructure and services to the scientific community.

Differentiator

Problem solved

Functional benefit

Products and services

• Biobank Platform Storage and management of biological samples to support biomedical research conducted by IDIBAPS research groups and collaborators.
• Medical Statistics Platform Statistical support and analysis services for clinical and biomedical research data used by IDIBAPS research groups.
• Magnetic Resonance Imaging Platform Advanced MRI imaging services for biomedical research applications used by IDIBAPS-affiliated research groups.
• Cytometry and Cell Separation Platform Cell analysis and sorting services using flow cytometry technology for biomedical research at IDIBAPS.
• Functional Genomics Platform Genomic analysis and functional study services supporting gene behavior and interaction research at IDIBAPS.
• Clinical Trials Unit Infrastructure and support services for the design and execution of clinical research trials conducted at IDIBAPS.
• Scientific Computing Platform High-performance computing and data analysis infrastructure for biomedical research at IDIBAPS.
• SIMClínic Clinical simulation training program for medical professionals and students using advanced simulation techniques.
• Doctoral Research Training Supervision and training of doctoral candidates across IDIBAPS research groups, producing approximately 100 doctoral theses per year.
• Knowledge and Technology Transfer Program Programs that translate IDIBAPS research outputs into clinical and commercial applications, in collaboration with Hospital Clínic and Universitat de Barcelona.

Quantifiable outcome

• Over 1,200 original articles published per year
• +2 more outcomes

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Hospital ClíniccoreStrategic or Co-development PartnerHospital Clínic is the primary clinical affiliate of IDIBAPS, providing the clinical environment where research is conducted and translated into patient care.
• Universitat de BarcelonacoreStrategic or Co-development PartnerThe University of Barcelona is an institutional partner providing academic affiliation and research collaboration for IDIBAPS.
• Generalitat de CatalunyacoreStrategic or Co-development PartnerRegional government of Catalonia provides institutional support and funding for IDIBAPS as part of the Catalan research ecosystem.
• CERCAcoreStrategic or Co-development PartnerCERCA (Centres de Recerca de Catalunya) is the Catalan research centers association that includes IDIBAPS as a member institution.
• REGICminorStrategic or Co-development PartnerNetwork of clinical research groups in Catalonia that IDIBAPS participates in for collaborative research initiatives.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Broad Institute: US-based biomedical and genomic research institute affiliated with MIT and Harvard. Comparable in its translational research model combining genomics, clinical insight, and platform infrastructure, though at a much larger operational scale.
• Karolinska Institutet: Sweden's leading medical university with significant biomedical research output and hospital integration. Comparable as a publicly funded biomedical research entity with university affiliation, though much larger in size and direct clinical footprint.
• Francis Crick Institute: London-based biomedical discovery research institute operating on a comparable consortium/public-funding model with hospital and university affiliations. Comparable in multi-disciplinary research group structure, though at substantially larger scale than IDIBAPS.
• Helmholtz Munich: Large German public research center for environmental health and biomedical research. Comparable in public funding model, multi-platform core facility structure, and translational research scope, though more disease-broad than IDIBAPS.

Direct peers

• Vall d'Hebron Institute of Oncology (VHIO): Barcelona-based translational cancer research institute affiliated with the Vall d'Hebron University Hospital. Comparable to IDIBAPS in its hospital-embedded research model, multi-group structure, and translational mission focused on oncology.
• Centre for Genomic Regulation (CRG): Barcelona-based public research institute focused on genomics and systems biology, co-located with IDIBAPS in the Barcelona biomedical cluster. Comparable in scale, CERCA membership, and core facility-driven research model.
• IRB Barcelona: Institute for Research in Biomedicine, a public biomedical research institute also based in Barcelona and member of the CERCA network. Highly comparable to IDIBAPS in mission (translational biomedical research), funding model (competitive grants), scale, and proximity to leading hospitals.
• Institute for Bioengineering of Catalonia (IBEC): CERCA-affiliated public research institute in Barcelona focused on bioengineering and nanomedicine. Comparable in consortium structure, public funding model, and proximity within the BIST/CERCA research ecosystem.

Regional players

• CIMA (University of Navarra): University of Navarra's biomedical research center, comparable in size, university/hospital embedding, and translational mission, but operating in a different Spanish region.
• Spanish National Cancer Research Centre (CNIO): Madrid-based public cancer research center of similar scale and funding model to IDIBAPS. Comparable in being a Spanish publicly funded biomedical research institute, though geographically distinct and more disease-focused (cancer only).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/idibaps
• YouTubeyoutube.com/channel/UCCFnAQSQQTc8OsN2A1X6nJg
• Facebookfacebook.com/idibaps
• LinkedInlinkedin.com/company/idibaps

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IDIBAPS